31 January - 1 February 2018
Theme: ‘Current concepts: what to explore further vs implement?’
From the crack-down on opioid treatment programs to the role of neoadjuvant therapy on pancreatic tumours, gastroenterology is arguably one of the most medically researched and debated subjects in medicine.
To stay up to date on the latest evidence-based medicine, the 10th Gastroenterology conference delivered a comprehensive overview of the latest information, insights and practices in gastroenterology, hepatology, endoscopy and more.
The agenda provided a forum for all gastroenterologists within the region to exchange ideas, discuss innovative methods and review new developments within the field of gastroenterology. The program addressed the hottest topics and controversies as well as the latest in essential knowledge to reduce procedural complications and hasten patient recovery.
Co-Chairs:
Activity Director:
Dr Nizar Zein, Chairman, Global Patient Services, Mikati Foundation Endowed Chair and Chief of Hepatology, Cleveland Clinic, Cleveland, Ohio, USA
Disclaimer: The UAE has announced that it will introduce VAT on 1 January 2018 at a rate to be determined (currently expected to be 5%). Any delegate fees for events taking place in 2018 may be subject to this VAT and we are waiting for the legislation to be finalised and further guidance issued. Any applicable VAT will be invoiced in addition to the prices mentioned on the registration form.
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this live activity for a maximum of 13.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
09:15 Opening remarks
Prof Dr Mustafa Sabri, Professor of Medicine, Consultant Gastroenterologist, Rashid Hospital, General Secretary, Emirates Gastroenterology and Hepatology Society, Dubai, UAE
Dr Nigel Beejay, Consultant Physician, Gastroenterologist and Hepatologist, Advanced Center for Daycare Surgery, Abu Dhabi, UAE
SESSION 1: UPPER GI DISEASES
Moderator: Prof Dr Mustafa Sabri, Professor of Medicine, Consultant Gastroenterologist, Rashid Hospital, General Secretary, Emirates Gastroenterology and Hepatology Society, Dubai, UAE
09:30 GERD vs non-GERD – evaluation, PPI safety, cost implications
Dr Adnan Muhammad, Consultant Gastroenterologist and Transplant Hepatologist, American Hospital, Dubai, UAE
10:00 Is all upper abdominal pain dyspepsia?
Dr Nigel Beejay, Consultant Physician, Gastroenterologist and Hepatologist, Advanced Center for Daycare Surgery, Abu Dhabi, UAE
10:30 Q&A
10:40 Coffee Break
SESSION 2: KEYNOTE ADDRESS
Moderator: Dr Nigel Beejay, Consultant Physician, Gastroenterologist and Hepatologist, Advanced Center for Daycare Surgery, Abu Dhabi, UAE
11:10 Keynote: What gastroenterology service will look like in 10 years – the role of endoscopy
Dr Anthony Kalloo, Chief, Division of Gastroenterology and Hepatology, Professor of Medicine, The Johns Hopkins Hospital, Baltimore, Maryland, USA
12:10 Q&A
12:20 Lunch Break
SESSION 3: THE LATEST IN INFLAMMATORY BOWEL DISEASE
Moderator: Prof Dr Mustafa Sabri, Professor of Medicine, Consultant Gastroenterologist, Rashid Hospital, General Secretary, Emirates Gastroenterology and Hepatology Society, Dubai, UAE
13:30 IBD surveillance
Prof Dr Mustafa Sabri, Professor of Medicine, Consultant Gastroenterologist, Rashid Hospital, General Secretary, Emirates Gastroenterology and Hepatology Society, Dubai, UAE
14:00 IBD ECCO guidelines
Dr Marcus Harbord, Consultant Gastroenterologist, Imperial College London, Chelsea and Westminster Hospital, London, UK
14:30 Biosimilars in the treatment of IBD
Dr Nigel Beejay, Consultant Physician, Gastroenterologist and Hepatologist, Advanced Center for Daycare Surgery, Abu Dhabi, UAE
15:00 Twin studies in IBD - epigenetics and metabolomics
Dr Marcus Harbord, Consultant Gastroenterologist, Imperial College London, Chelsea and Westminster Hospital, London, UK
15:30 Q&A
15:45 Coffee Break
SESSION 4: PAEDIATRIC GASTROENTEROLOGY
Moderator: Prof Dr Mustafa Sabri, Professor of Medicine, Consultant Gastroenterologist, Rashid Hospital, General Secretary, Emirates Gastroenterology and Hepatology Society, Dubai, UAE
16:15 Update on evaluation and treatment of motility disorders in children
Dr Carlo Di Lorenzo, Professor of Pediatrics, The Ohio State University, Chief of the Division of Pediatric Gastroenterology, Hepatology and Nutrition, Nationwide Children’s Hospital, Columbus, Ohio, USA
16:45 Eosinophilic Eosophagitis
Dr Mohammed Mikdady, Consultant Paediatric Gastroenterologist, Sheikh Khalifa Medical City, Abu Dhabi, UAE
17:15 Paediatric hepatology
Dr Rajeev Tomar, Consultant Paediatrician, Medical Director, King’s College Hospital, Abu Dhabi, UAE
17:45 Q&A
18:00 End of Day One
08:30 Opening remarks
Prof Dr Mustafa Sabri, Professor of Medicine, Consultant Gastroenterologist, Rashid Hospital, General Secretary, Emirates Gastroenterology and Hepatology Society, Dubai, UAE
Dr Nigel Beejay, Consultant Physician, Gastroenterologist and Hepatologist, Advanced Center for Daycare Surgery, Abu Dhabi, UAE
SESSION 5: GI ONCOLOGY REVIEW
Moderator: Dr Nizar Zein, Chairman, Global Patient Services, Mikati Foundation Endowed Chair and Chief of Hepatology, Cleveland Clinic, Cleveland, Ohio, USA
08:40 Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma
Dr Nevena Damjanov, Professor of Clinical Medicine, Attending Physician, Hospital of the University of Pennsylvania, Attending Physician, Penn Presbyterian Medical Center, Director of GI Oncology, Abramson Cancer Center, Director, Clinical Research Program, Abramson Cancer Center, Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, USA
09:10 Multidisciplinary approach to manage hepatocellular cancer
Dr Nizar Zein, Chairman, Global Patient Services, Mikati Foundation Endowed Chair and Chief of Hepatology, Cleveland Clinic, Cleveland, Ohio, USA
09:40 Cholangiocarcinoma – an oncologic perspective
Dr Nevena Damjanov, Professor of Clinical Medicine, Attending Physician, Hospital of the University of Pennsylvania, Attending Physician, Penn Presbyterian Medical Center, Director of GI Oncology, Abramson Cancer Center, Director, Clinical Research Program, Abramson Cancer Center, Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, USA
10:10 Coffee Break
SESSION 6: NEW RESEARCH AND INTERVENTIONS
Moderator: Dr Nigel Beejay, Consultant Physician, Gastroenterologist and Hepatologist, Advanced Center for Daycare Surgery, Abu Dhabi, UAE
10:40 Hepatitis C – latest update
Prof Dr Mostafa Ibrahim, Lecturer of Gastroenterology and Endoscopy, Theodor Bilharz Research Institute, Cairo, Egypt Lecturer of Gastroenterology and Endoscopy, Theodor Bilharz Research Institute, Cairo, Egypt
11:10 New interventions for treatment of gastroparesis: From stimulators to endoscopic myotomy
Dr Matthew Kroh, Associate Professor of Surgery, Cleveland Clinic Lerner College of Medicine, Institute Chief, Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE
11:40 New auto-immune diseases – the nascent role of IgG4
Dr Makki Fayyadh, Consultant Gastroenterologist and Hepatologist, Advanced Center Daycare Surgery, Abu Dhabi, UAE
12:10 Paediatric gut microbiota - the third brain
Dr Mohammed Azzam Kayasseh, Specialist Gastroenterologist, Dr Kayasseh Medical Clinic, Dubai, UAE
12:40 Q&A
12:50 Lunch Break
SESSION 7: BARIATRIC SURGERY AND OBESITY: THE GOOD, THE BAD AND THE COMPLICATED
Moderator: Dr Matthew Kroh, Associate Professor of Surgery, Cleveland Clinic Lerner College of Medicine, Institute Chief, Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE
14:00 Endoscopic metabolic therapies
Dr Kelvin Higa, Medical Director, Fresno Bariatrics, President, International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO), Fresno, California, USA
14:30 Obesity surgery – when things go awry
Dr Shaw Somers, Consultant Specialist: Upper GI and Bariatric Surgeon, BMI Clementine Churchill Hospital London and Portsmouth Hospitals NHS Trust, Portsmouth, UK
15:00 Q&A
15:10 Coffee Break
SESSION 8: LIVER
Moderator: Dr Nizar Zein, Chairman, Global Patient Services, Mikati Foundation Endowed Chair and Chief of Hepatology, Cleveland Clinic, Cleveland, Ohio, USA
15:40 Optimal treatment for fatty liver disease
Dr Salem Awadh, Consultant Gastroenterologist and Hepatologist, Burjeel Hospital, Abu Dhabi, UAE
16:10 Portal hypertension; Guidelines Vs How I do it
Prof Dr Ibrahim Mostafa, Professor of Gastroenterology and Hepatology, Vice President, Theodor Bilharz Research Institute, Cairo, Egypt
16:40 Open mic Q&A and interactive audience discussion session
17:20 End of Conference
Activity Director:
Dr Nizar Zein, Chairman, Global Patient Services, Mikati Foundation Endowed Chair and Chief of Hepatology, Cleveland Clinic, Cleveland, Ohio, USA
Conference Chair:
Prof Dr Mustafa Sabri, Professor of Medicine, Consultant Gastroenterologist, Rashid Hospital, General Secretary, Emirates Gastroenterology and Hepatology Society, Dubai, UAE
Conference co-Chair:
Dr Nigel Beejay, Consultant Physician, Gastroenterologist and Hepatologist, Advanced Center for Daycare Surgery, Abu Dhabi, UAE
SPEAKER FACULTY:
Dr Adnan Muhammad, Consultant Gastroenterologist and Transplant Hepatologist, American Hospital, Dubai, UAE
Dr Anthony Kalloo, Chief, Division of Gastroenterology and Hepatology, Professor of Medicine, The Johns Hopkins Hospital, Baltimore, Maryland, USA
Dr Carlo Di Lorenzo, Professor of Pediatrics, The Ohio State University, Chief of the Division of Pediatric Gastroenterology, Hepatology and Nutrition, Nationwide Children’s Hospital, Columbus, Ohio, USA
Dr Mostafa Ibrahim, Lecturer of Gastroenterology and Endoscopy, Theodor Bilharz Research Institute, Cairo, Egypt
Dr Kelvin Higa, Medical Director, Fresno Bariatrics, President, International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO), Fresno, California, USA
Dr Makki Fayyadh, Consultant Gastroenterologist and Hepatologist, Advanced Center Daycare Surgery, Abu Dhabi, UAE
Dr Marcus Harbord, Consultant Gastroenterologist, Imperial College London, Chelsea and Westminster Hospital, London, UK
Dr Matthew Kroh, Associate Professor of Surgery, Cleveland Clinic Lerner College of Medicine, Institute Chief, Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE
Dr Mohammed Azzam Kayasseh, Specialist Gastroenterologist, Dr Kayasseh Medical Clinic, Dubai, UAE
Dr Mohammed Mikdadi, Consultant Paediatric Gastroenterologist, Sheikh Khalifa Medical City, Abu Dhabi, UAE
Dr Nevena Damjanov, Professor of Clinical Medicine, Attending Physician, Hospital of the University of Pennsylvania, Attending Physician, Penn Presbyterian Medical Center, Director of GI Oncology, Abramson Cancer Center, Director, Clinical Research Program, Abramson Cancer Center, Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, USA
Dr Rajeev Tomar, Consultant Paediatrician, Medical Director, King’s College Hospital, Abu Dhabi, UAE
Dr Salem Awadh, Consultant Gastroenterologist and Hepatologist, Burjeel Hospital, Abu Dhabi, UAE
Dr Shaw Somers, Consultant Specialist: Upper GI and Bariatric Surgeon, BMI Clementine Churchill Hospital London and Portsmouth Hospitals NHS Trust, Portsmouth, UK